Corey Baker - Nov 14, 2024 Form 4 Insider Report for Vita Coco Company, Inc. (COCO)

Signature
By: Alison Klein, Attorney-in-Fact For: Corey Baker
Stock symbol
COCO
Transactions as of
Nov 14, 2024
Transactions value $
-$175,988
Form type
4
Date filed
11/18/2024, 04:27 PM
Previous filing
Mar 15, 2024
Next filing
Dec 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COCO Common Stock Sale -$176K -5.17K -10.04% $34.03 46.3K Nov 14, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding COCO Non-Qualified Stock Option (right to buy) 14.2K Nov 14, 2024 Common Stock 14.2K $16.91 Direct F3
holding COCO Non-Qualified Stock Option (right to buy) 13.5K Nov 14, 2024 Common Stock 13.5K $24.35 Direct F4
holding COCO Non-Qualified Stock Option (right to buy) 8.75K Nov 14, 2024 Common Stock 8.75K $26.18 Direct F5
holding COCO Non-Qualified Stock Option (right to buy) 11.5K Nov 14, 2024 Common Stock 11.5K $27.59 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.80 to $34.56, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The stock option vests in four equal annual installments beginning on March 10, 2024.
F4 The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
F5 The stock option vests in four equal annual installments beginning on March 4, 2025.